Cristiane Decat Bergerot PhD, Paulo Gustavo Bergerot MD, Marianne Razavi PhD, Marcos Vinicius da Silva França MD, MS, Jonas Ribeiro Gomes da Silva BS, Jose Adolfo Cerveira MD, William Hiromi Fuzita MD, Gabriel Marques dos Anjos MD, Renata Ferrari BS, Errol J. Philip PhD, Mariana Tosello Laloni MD, Carlos Gil Moreira Ferreira MD, PhD, Marco Murilo Buso MD, Sumanta K. Pal MD, Ryan Nipp MD, MPH, Areej El-Jawahri MD, Enrique Soto-Perez-de-Celis MD, PhD, William Dale MD, PhD
{"title":"The impact of a geriatric assessment-guided management intervention (GAIN-S) on prognostic awareness: A randomized controlled trial","authors":"Cristiane Decat Bergerot PhD, Paulo Gustavo Bergerot MD, Marianne Razavi PhD, Marcos Vinicius da Silva França MD, MS, Jonas Ribeiro Gomes da Silva BS, Jose Adolfo Cerveira MD, William Hiromi Fuzita MD, Gabriel Marques dos Anjos MD, Renata Ferrari BS, Errol J. Philip PhD, Mariana Tosello Laloni MD, Carlos Gil Moreira Ferreira MD, PhD, Marco Murilo Buso MD, Sumanta K. Pal MD, Ryan Nipp MD, MPH, Areej El-Jawahri MD, Enrique Soto-Perez-de-Celis MD, PhD, William Dale MD, PhD","doi":"10.1002/cncr.70054","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Background</h3>\n \n <p>Geriatric assessment (GA)-guided supportive care (GAIN-S) may improve decision-making in older adults with cancer, but its effects on prognostic awareness remain unclear. The authors evaluated whether GAIN-S enhances prognostic awareness among older adults with metastatic cancer in Brazil.</p>\n </section>\n \n <section>\n \n <h3> Methods</h3>\n \n <p>This randomized controlled trial was conducted in Brazil (June 2022–July 2023). Adults ≥65 years old with metastatic cancer were randomized 1:1 to GAIN-S (<i>n</i> = 39) or usual care (UC; <i>n</i> = 38). GAIN-S included multidisciplinary GA review, individualized care planning, and targeted referrals. UC consisted of standard care without GA-guided interventions. Prognostic awareness was assessed using the Prognostic Awareness Impact Questionnaire, covering emotional (10 items; range, 0–30), adaptive (12 items; range, 0–36), and cognitive (2 categorical items) domains. Group differences were analyzed using <i>t</i>-tests; item-level analyses used Mann-Whitney <i>U</i>, McNemar’s, or χ<sup>2</sup> tests.</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>Seventy-seven participants were enrolled (mean age, 74.5; 56% female). Common cancers included genitourinary (29.9%), breast (24.7%), and gastrointestinal (22.1%). GAIN-S led to greater improvements in emotional (mean difference = 1.14, standard error [SE] = 0.35, <i>p</i> = .002) and adaptive (mean difference = 0.82, SE = 0.30, <i>p</i> = .008) domains compared to UC. No differences were observed in the cognitive domain. Most participants reported their oncologist had not clearly stated whether their cancer was curable (74% GAIN-S vs. 57% UC). GAIN-S participants more often reported improved coping with prognostic uncertainty, better emotional acceptance, and reduced distress (all <i>p</i> < .05).</p>\n </section>\n \n <section>\n \n <h3> Conclusions</h3>\n \n <p>GAIN-S improved emotional and adaptive domains of prognostic awareness. These novel findings underscore the value of the GAIN-S intervention for older adults. Studies are needed to explore longer-term effects on decision-making, communication, and quality of life.</p>\n </section>\n </div>","PeriodicalId":138,"journal":{"name":"Cancer","volume":"131 17","pages":""},"PeriodicalIF":5.1000,"publicationDate":"2025-08-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cancer","FirstCategoryId":"3","ListUrlMain":"https://acsjournals.onlinelibrary.wiley.com/doi/10.1002/cncr.70054","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background
Geriatric assessment (GA)-guided supportive care (GAIN-S) may improve decision-making in older adults with cancer, but its effects on prognostic awareness remain unclear. The authors evaluated whether GAIN-S enhances prognostic awareness among older adults with metastatic cancer in Brazil.
Methods
This randomized controlled trial was conducted in Brazil (June 2022–July 2023). Adults ≥65 years old with metastatic cancer were randomized 1:1 to GAIN-S (n = 39) or usual care (UC; n = 38). GAIN-S included multidisciplinary GA review, individualized care planning, and targeted referrals. UC consisted of standard care without GA-guided interventions. Prognostic awareness was assessed using the Prognostic Awareness Impact Questionnaire, covering emotional (10 items; range, 0–30), adaptive (12 items; range, 0–36), and cognitive (2 categorical items) domains. Group differences were analyzed using t-tests; item-level analyses used Mann-Whitney U, McNemar’s, or χ2 tests.
Results
Seventy-seven participants were enrolled (mean age, 74.5; 56% female). Common cancers included genitourinary (29.9%), breast (24.7%), and gastrointestinal (22.1%). GAIN-S led to greater improvements in emotional (mean difference = 1.14, standard error [SE] = 0.35, p = .002) and adaptive (mean difference = 0.82, SE = 0.30, p = .008) domains compared to UC. No differences were observed in the cognitive domain. Most participants reported their oncologist had not clearly stated whether their cancer was curable (74% GAIN-S vs. 57% UC). GAIN-S participants more often reported improved coping with prognostic uncertainty, better emotional acceptance, and reduced distress (all p < .05).
Conclusions
GAIN-S improved emotional and adaptive domains of prognostic awareness. These novel findings underscore the value of the GAIN-S intervention for older adults. Studies are needed to explore longer-term effects on decision-making, communication, and quality of life.
期刊介绍:
The CANCER site is a full-text, electronic implementation of CANCER, an Interdisciplinary International Journal of the American Cancer Society, and CANCER CYTOPATHOLOGY, a Journal of the American Cancer Society.
CANCER publishes interdisciplinary oncologic information according to, but not limited to, the following disease sites and disciplines: blood/bone marrow; breast disease; endocrine disorders; epidemiology; gastrointestinal tract; genitourinary disease; gynecologic oncology; head and neck disease; hepatobiliary tract; integrated medicine; lung disease; medical oncology; neuro-oncology; pathology radiation oncology; translational research